Leadership changes at PhRMA
This article was originally published in Scrip
Executive Summary
The US innovator trade group PhRMAhas announced a number of leadership changes. Executive vice-president and chief operating officer Chris Singer has been named president of the international section. Diane Bieri, formerly senior vice-president, has been promoted to executive vice-president and remains general counsel. Chris Badgley will assume expanded duties as senior vice-president for government and public affairs; he previously was vice-president of state government affairs. International affairs vice-president Brian Toohey has been promoted to senior vice-president, and Jeff May has been named vice-president of international affairs. Federal affairs senior vice-president Alan Gilbert is leaving PhRMA in January to start his own consulting firm. He will be replaced by Bryant Hall, currently vice-president of federal affairs.
You may also be interested in...
Rare Diseases: CBER Looks To ‘Lean Into’ Accelerated Approval, Align More With CDER
US FDA biologics center officials spoke about their efforts to increase collaboration and harmonization with the drugs center, and to internally involve more review disciplines in evaluating biomarker evidence, during a Reagan-Udall Foundation meeting that weighed potential use of accelerated approval for neuronopathic mucopolysaccharidoses disorders.
RWE: Non-Interventional Studies Must Be Able To Distinguish A True Treatment Effect, US FDA Says
Agency describes a host of issues sponsors should consider and address before pursuing observational or case-control studies to support regulatory decision-making on drug efficacy or safety; new draft guidance was issued under the FDA’s Real-World Evidence program.
Eye On ODAC: Former Members, FDA’s Pazdur Talk Pre-Meeting Mindsets, Impact Of Sponsor’s Experts
Oncologic Drugs Advisory Committee reps and the Oncology Center of Excellence director go behind the scenes to discuss FDA interactions with panelists, how opinions can change during a meeting, and why the voting question is important.